327 related articles for article (PubMed ID: 26497678)
1. Therapeutic potential of targeting cell division cycle associated 5 for oral squamous cell carcinoma.
Tokuzen N; Nakashiro K; Tanaka H; Iwamoto K; Hamakawa H
Oncotarget; 2016 Jan; 7(3):2343-53. PubMed ID: 26497678
[TBL] [Abstract][Full Text] [Related]
2. Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma.
Wang J; Xia C; Pu M; Dai B; Yang X; Shang R; Yang Z; Zhang R; Tao K; Dou K
Oncol Rep; 2018 Oct; 40(4):1875-1884. PubMed ID: 30015982
[TBL] [Abstract][Full Text] [Related]
3. Identification of Akt1 as a potent therapeutic target for oral squamous cell carcinoma.
Nakashiro K; Tanaka H; Goda H; Iwamoto K; Tokuzen N; Hara S; Onodera J; Fujimoto I; Hino S; Hamakawa H
Int J Oncol; 2015 Oct; 47(4):1273-81. PubMed ID: 26315674
[TBL] [Abstract][Full Text] [Related]
4. Acylglycerol kinase promotes the proliferation and cell cycle progression of oral squamous cell carcinoma.
Liu G; Ren X; Gao C; Zhang W
Mol Med Rep; 2015 Aug; 12(2):2225-30. PubMed ID: 25872568
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation and activation of cell division cycle associated 5 by mitogen-activated protein kinase play a crucial role in human lung carcinogenesis.
Nguyen MH; Koinuma J; Ueda K; Ito T; Tsuchiya E; Nakamura Y; Daigo Y
Cancer Res; 2010 Jul; 70(13):5337-47. PubMed ID: 20551060
[TBL] [Abstract][Full Text] [Related]
6. Targeting l1 cell adhesion molecule using lentivirus-mediated short hairpin RNA interference reverses aggressiveness of oral squamous cell carcinoma.
Hung SC; Wu IH; Hsue SS; Liao CH; Wang HC; Chuang PH; Sung SY; Hsieh CL
Mol Pharm; 2010 Dec; 7(6):2312-23. PubMed ID: 21033655
[TBL] [Abstract][Full Text] [Related]
7. Oxysophocarpine Retards the Growth and Metastasis of Oral Squamous Cell Carcinoma by Targeting the Nrf2/HO-1 Axis.
Liu R; Peng J; Wang H; Li L; Wen X; Tan Y; Zhang L; Wan H; Chen F; Nie X
Cell Physiol Biochem; 2018; 49(5):1717-1733. PubMed ID: 30231242
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo antitumor effects of chloroquine on oral squamous cell carcinoma.
Jia L; Wang J; Wu T; Wu J; Ling J; Cheng B
Mol Med Rep; 2017 Nov; 16(5):5779-5786. PubMed ID: 28849182
[TBL] [Abstract][Full Text] [Related]
9. Effect of silencing of mediator of DNA damage checkpoint protein 1 on the growth of oral squamous cell carcinoma in vitro and in vivo.
Zhang X; Hu F; Liu L; Xu B
Eur J Oral Sci; 2019 Dec; 127(6):494-499. PubMed ID: 31786813
[TBL] [Abstract][Full Text] [Related]
10. Systematic cancer-testis gene expression analysis identified CDCA5 as a potential therapeutic target in esophageal squamous cell carcinoma.
Xu J; Zhu C; Yu Y; Wu W; Cao J; Li Z; Dai J; Wang C; Tang Y; Zhu Q; Wang J; Wen W; Xue L; Zhen F; Liu J; Huang C; Zhao F; Zhou Y; He Z; Pan X; Wei H; Zhu Y; He Y; Que J; Luo J; Chen L; Wang W
EBioMedicine; 2019 Aug; 46():54-65. PubMed ID: 31324603
[TBL] [Abstract][Full Text] [Related]
11. Daxx and TCF4 interaction links to oral squamous cell carcinoma growth by promoting cell cycle progression via induction of cyclin D1 expression.
Lin GJ; Huang YS; Lin CK; Huang SH; Shih HM; Sytwu HK; Chen YW
Clin Oral Investig; 2016 Apr; 20(3):533-40. PubMed ID: 26205068
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of miR-187 modulates the advances of oral carcinoma by targeting BARX2 tumor suppressor.
Lin SC; Kao SY; Chang JC; Liu YC; Yu EH; Tseng SH; Liu CJ; Chang KW
Oncotarget; 2016 Sep; 7(38):61355-61365. PubMed ID: 27542258
[TBL] [Abstract][Full Text] [Related]
13. Exosomes containing miR-21 transfer the characteristic of cisplatin resistance by targeting PTEN and PDCD4 in oral squamous cell carcinoma.
Liu T; Chen G; Sun D; Lei M; Li Y; Zhou C; Li X; Xue W; Wang H; Liu C; Xu J
Acta Biochim Biophys Sin (Shanghai); 2017 Sep; 49(9):808-816. PubMed ID: 28910982
[TBL] [Abstract][Full Text] [Related]
14. Cell division cycle 7 is a potential therapeutic target in oral squamous cell carcinoma and is regulated by E2F1.
Jin S; Ma H; Yang W; Ju H; Wang L; Zhang Z
J Mol Med (Berl); 2018 Jun; 96(6):513-525. PubMed ID: 29713760
[TBL] [Abstract][Full Text] [Related]
15. CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway.
Ji J; Shen T; Li Y; Liu Y; Shang Z; Niu Y
Oncol Rep; 2021 Mar; 45(3):921-932. PubMed ID: 33650660
[TBL] [Abstract][Full Text] [Related]
16. MiR-92a regulates oral squamous cell carcinoma (OSCC) cell growth by targeting FOXP1 expression.
Guo J; Wen N; Yang S; Guan X; Cang S
Biomed Pharmacother; 2018 Aug; 104():77-86. PubMed ID: 29772443
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of CDCA5 promotes gastric cancer malignant progression via influencing cyclin E1.
Zhang Z; Shen M; Zhou G
Biochem Biophys Res Commun; 2018 Feb; 496(2):482-489. PubMed ID: 29326043
[TBL] [Abstract][Full Text] [Related]
18. Caffeic acid phenethyl ester upregulates N-myc downstream regulated gene 1 via ERK pathway to inhibit human oral cancer cell growth in vitro and in vivo.
Chung LC; Chiang KC; Feng TH; Chang KS; Chuang ST; Chen YJ; Tsui KH; Lee JC; Juang HH
Mol Nutr Food Res; 2017 Sep; 61(9):. PubMed ID: 28181403
[TBL] [Abstract][Full Text] [Related]
19. Long Non Coding RNA MALAT1 Promotes Tumor Growth and Metastasis by inducing Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma.
Zhou X; Liu S; Cai G; Kong L; Zhang T; Ren Y; Wu Y; Mei M; Zhang L; Wang X
Sci Rep; 2015 Nov; 5():15972. PubMed ID: 26522444
[TBL] [Abstract][Full Text] [Related]
20. Targeting Aurora kinase A suppresses the growth of human oral squamous cell carcinoma cells in vitro and in vivo.
Tanaka H; Nakashiro K; Iwamoto K; Tokuzen N; Fujita Y; Shirakawa R; Oka R; Goda H; Hamakawa H
Oral Oncol; 2013 Jun; 49(6):551-9. PubMed ID: 23481312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
